H
Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
KRX:293480
Price:
9 790
KRW
-1.51%
Market Closed
Market Cap:
₩174B
Balance Sheet
Balance Sheet Decomposition
Hana Pharm Co Ltd
Hana Pharm Co Ltd
Balance Sheet Decomposition is not available for
Hana Pharm Co Ltd
Hana Pharm Co Ltd
Balance Sheet
Hana Pharm Co Ltd
Hana Pharm Co Ltd
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
568
|
1 389
|
12 941
|
16 988
|
14 985
|
20 546
|
6 615
|
12 548
|
1 425
|
8 517
|
|
| Cash |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
568
|
1 388
|
12 940
|
16 987
|
14 985
|
20 546
|
6 615
|
12 548
|
1 425
|
8 517
|
|
| Short-Term Investments |
3 098
|
1 770
|
3 550
|
89 323
|
74 425
|
52 830
|
50 251
|
5 034
|
2 000
|
200
|
|
| Total Receivables |
34 853
|
38 633
|
43 060
|
43 034
|
42 427
|
43 511
|
42 780
|
44 306
|
46 167
|
43 251
|
|
| Accounts Receivables |
29 626
|
34 410
|
37 554
|
36 658
|
36 477
|
37 778
|
35 382
|
35 724
|
37 558
|
36 676
|
|
| Other Receivables |
5 227
|
4 223
|
5 506
|
6 376
|
5 950
|
5 732
|
7 398
|
8 582
|
8 609
|
6 574
|
|
| Inventory |
14 386
|
18 027
|
19 270
|
22 006
|
26 886
|
30 730
|
40 693
|
41 404
|
48 347
|
47 436
|
|
| Other Current Assets |
84
|
658
|
578
|
220
|
166
|
178
|
116
|
235
|
4 482
|
6 589
|
|
| Total Current Assets |
52 989
|
60 476
|
79 398
|
171 572
|
158 888
|
147 794
|
140 455
|
103 527
|
102 421
|
105 992
|
|
| PP&E Net |
40 609
|
49 664
|
46 653
|
46 314
|
78 275
|
93 074
|
122 399
|
151 868
|
157 841
|
186 497
|
|
| PP&E Gross |
0
|
49 664
|
46 653
|
46 314
|
78 275
|
93 074
|
122 399
|
151 868
|
157 841
|
186 497
|
|
| Accumulated Depreciation |
0
|
35 949
|
38 795
|
42 510
|
45 276
|
50 073
|
52 395
|
55 473
|
60 014
|
64 554
|
|
| Intangible Assets |
2 167
|
1 986
|
3 384
|
5 319
|
5 480
|
7 975
|
12 837
|
11 990
|
14 402
|
15 751
|
|
| Long-Term Investments |
778
|
1 152
|
9 443
|
16 283
|
16 229
|
20 933
|
24 182
|
72 104
|
68 960
|
69 203
|
|
| Other Long-Term Assets |
897
|
1 315
|
2 673
|
2 892
|
4 162
|
6 804
|
3 624
|
6 476
|
4 762
|
4 568
|
|
| Total Assets |
97 440
N/A
|
114 592
+18%
|
141 551
+24%
|
242 380
+71%
|
263 034
+9%
|
276 579
+5%
|
303 497
+10%
|
345 965
+14%
|
348 386
+1%
|
382 011
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6 332
|
6 921
|
7 352
|
6 330
|
6 938
|
6 032
|
6 678
|
8 064
|
6 447
|
6 656
|
|
| Accrued Liabilities |
2 195
|
2 102
|
2 303
|
2 598
|
2 613
|
2 926
|
1 723
|
2 726
|
2 929
|
3 033
|
|
| Short-Term Debt |
7 691
|
1 751
|
1 730
|
469
|
1 064
|
1 000
|
8 397
|
10 445
|
3 438
|
2 000
|
|
| Current Portion of Long-Term Debt |
5 191
|
8 028
|
21 102
|
2 612
|
2 618
|
2 603
|
1 148
|
1 523
|
21 496
|
2 768
|
|
| Other Current Liabilities |
12 657
|
15 293
|
16 226
|
17 619
|
20 424
|
21 677
|
22 899
|
21 947
|
21 815
|
17 368
|
|
| Total Current Liabilities |
34 066
|
34 095
|
48 713
|
29 628
|
33 658
|
34 237
|
40 845
|
44 704
|
56 126
|
31 826
|
|
| Long-Term Debt |
26 389
|
21 155
|
6 214
|
1 568
|
1 773
|
897
|
1 230
|
22 132
|
1 599
|
24 359
|
|
| Deferred Income Tax |
1 279
|
1 464
|
1 213
|
457
|
0
|
314
|
504
|
588
|
0
|
4 998
|
|
| Minority Interest |
0
|
0
|
358
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1 977
|
2 394
|
4 113
|
5 341
|
7 272
|
8 750
|
9 018
|
10 143
|
12 676
|
11 651
|
|
| Total Liabilities |
63 711
N/A
|
59 108
-7%
|
60 611
+3%
|
36 994
-39%
|
42 702
+15%
|
44 198
+4%
|
51 596
+17%
|
77 568
+50%
|
70 401
-9%
|
72 835
+3%
|
|
| Equity | |||||||||||
| Common Stock |
3 706
|
4 872
|
6 059
|
8 100
|
8 100
|
8 100
|
8 886
|
8 886
|
8 886
|
8 886
|
|
| Retained Earnings |
28 211
|
45 958
|
69 506
|
92 398
|
115 697
|
123 421
|
143 064
|
159 224
|
171 695
|
184 731
|
|
| Additional Paid In Capital |
1 800
|
2 495
|
3 200
|
105 243
|
105 246
|
105 246
|
104 459
|
104 459
|
104 459
|
104 459
|
|
| Unrealized Security Profit/Loss |
11
|
2 160
|
2 174
|
2 142
|
2 142
|
6 467
|
6 409
|
6 745
|
3 861
|
22 017
|
|
| Treasury Stock |
0
|
0
|
0
|
2 497
|
10 853
|
10 853
|
10 918
|
10 918
|
10 918
|
10 918
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
33 729
N/A
|
55 485
+65%
|
80 940
+46%
|
205 386
+154%
|
220 332
+7%
|
232 382
+5%
|
251 901
+8%
|
268 397
+7%
|
277 985
+4%
|
309 176
+11%
|
|
| Total Liabilities & Equity |
97 440
N/A
|
114 592
+18%
|
141 551
+24%
|
242 380
+71%
|
263 034
+9%
|
276 579
+5%
|
303 497
+10%
|
345 965
+14%
|
348 386
+1%
|
382 011
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
8
|
11
|
13
|
18
|
17
|
17
|
17
|
17
|
17
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
